Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. DEF 14A Proxy Proxy Statement
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 4 Insider Changes in Ownership

Page 4 of 69 · 1,379 filings